Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Cancer Surgery Trials

Buffalo, New York

Cancer surgery and procedure trials in Buffalo, NY

42 cancer surgery and procedure studies are recruiting participants at sites in Buffalo as of November 18, 2026, according to ClinicalTrials.gov. Cancer Surgery Trials can help you understand your options and connect with a study team.

Call (888) 350-9284
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Buffalo at a glance

  • 42 studies are recruiting at a site in Buffalo.
  • By phase: Phase 1/2 (3), Phase 2 (13), Phase 3 (16), Phase 4 (1), No phase (6), Observational (3). Studies of devices and behavioral approaches have no phase.
  • By sponsor: university, hospital or other (31), government (11).
  • By research area: Lymphoma (12), Lung Cancer (10), Breast Cancer (8), Pancreatic Cancer (5), Prostate Cancer (5), Melanoma (2).
  • Most recent update to one of these records: November 18, 2026.

Breast cancer studies recruiting in Buffalo

Basic details from each study's public record (the 30 most recently updated of 42). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

    • Phase 2
    • All ages
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT05564377 · updated
  2. Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT07391774 · updated
  3. Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects

    • No phase
    • Ages 18 and older
    • Female participants
    Sponsor
    Roswell Park Cancer Institute
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT03897270 · updated
  4. ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT06876714 · updated
  5. Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Cancer

    • No phase
    • Ages 21 and older
    • All sexes
    Sponsor
    Roswell Park Cancer Institute
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT05787834 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Buffalo, NY on ClinicalTrials.gov.

Lung cancer studies recruiting in Buffalo

  1. Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT07388524 · updated
  2. Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT04267848 · updated
  3. Hotspot Stereotactic Ablative Radiotherapy Versus Traditional Stereotactic Ablative Radiotherapy for the Treatment of Early-Stage Non-Small Cell Lung Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Roswell Park Cancer Institute
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT07718672 · updated
  4. Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT04181060 · updated
  5. New York Better Breathing Study

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Roswell Park Cancer Institute
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT06869447 · updated
  6. Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Roswell Park Cancer Institute
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT03965234 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Buffalo, NY on ClinicalTrials.gov.

Prostate cancer studies recruiting in Buffalo

  1. Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT06632977 · updated
  2. Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

    • Phase 3
    • Ages 18 and older
    • Male participants
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT06931340 · updated
  3. Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

    • Phase 3
    • Ages 18 and older
    • Male participants
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT07200830 · updated
  4. Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

    • Phase 3
    • Ages 18 and older
    • Male participants
    Sponsor
    SWOG Cancer Research Network
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT03678025 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Buffalo, NY on ClinicalTrials.gov.

Melanoma studies recruiting in Buffalo

  1. Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

    • Phase 3
    • Ages 75 and older
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT07068074 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Buffalo, NY on ClinicalTrials.gov.

Lymphoma studies recruiting in Buffalo

  1. Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

    • Phase 2
    • Up to 365 days
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT06317662 · updated
  2. A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

    • Phase 3
    • Ages 5 to 60
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT05675410 · updated
  3. Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT06649812 · updated
  4. Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

    • Phase 3
    • Ages 18 to 39
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT03150693 · updated
  5. Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma

    • Phase 3
    • Ages 60 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT05976763 · updated
  6. Collection of Tissue Samples for Cancer Research

    • Observational
    • From 2 months
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT00900198 · updated
  7. A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

    • Phase 2
    • From 366 days, up to 46 years
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT06124157 · updated
  8. Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Roswell Park Cancer Institute
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT06863402 · updated
  9. CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

    • Phase 1/2
    • From 12 months, up to 21 years
    • All sexes
    Sponsor
    Children's Oncology Group
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT04870944 · updated
  10. Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

    • Phase 3
    • From 365 days, up to 25 years
    • All sexes
    Sponsor
    Children's Oncology Group
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT03959085 · updated
  11. A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

    • Observational
    • Ages 7 and older
    • All sexes
    Sponsor
    Children's Oncology Group
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT05705531 · updated

Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Buffalo, NY on ClinicalTrials.gov.

Pancreatic cancer studies recruiting in Buffalo

  1. APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT04858334 · updated
  2. Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

    • Observational
    • Ages 50 to 75
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT04239573 · updated
  3. Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    NRG Oncology
    Study site
    Roswell Park Cancer Institute
    Registry record
    NCT06958328 · updated

Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Buffalo, NY on ClinicalTrials.gov.

Ask about studies near Buffalo

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in New York

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a surgery or another procedure, as each study is coded in the registry.

Cancer Surgery Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 350-9284

or send a short form

How should we reach you?

Call